The combination drug therapy now used to treat children born with HIV-1 appears to protect against previously common heart damage, according to a new study published earlier this week.
The study, funded by the National Institutes of Health (NIH), found that fewer HIV-positive children on today’s combination drug treatment had heart damage than those who participated in a study in the 1990s.




Follow us: